Jay LeCoque

Life Sciences

Jay is an experienced chief executive in the Life Sciences sector where his career spans more than 25 years. Jay worked for AptarGroup and Baxter Healthcare in various sales and market development roles. He joined Celsis International plc in 1995 as Director of Global Business Development and later became General Manager of US operations. He was appointed CEO of Celsis in November 2000. Under his leadership, Celsis was Best Performing Share in 2003 on the London Stock Exchange’s Techmark Mediscience Index. In 2009, Harwood Capital completed the public-to-private acquisition of Celsis, backing Jay as CEO. Over the next six years, Celsis continued to deliver double digit earnings growth and ultimately a 6.8 x cash return to shareholders. Since then Jay has continued to work closely with Harwood on its life sciences investments and is now executive chairman of portfolio company Source BioScience. Jay earned his MBA from Northwestern University’s Kellogg Graduate School of Management in Chicago and his BS from Miami University in Oxford, Ohio.